Underuse of generic medicines in Portugal: An empirical study on the perceptions and attitudes of patients and pharmacists

Health Policy

Volumn 104, Issue 1, 2012, Pages 61-68

  Quintal, Carlota ^a   Mendes, Patrícia ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Generic drug substitution; Patients' attitudes and perceptions; Pharmacists' attitudes; Portugal

Indexed keywords

GENERIC DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST CONTROL; DATA ANALYSIS SOFTWARE; DRUG SUBSTITUTION; EMPIRICISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT ATTITUDE; PERCEPTION; PHARMACIST ATTITUDE; PHYSICIAN; PORTUGAL; PRESCRIPTION; QUESTIONNAIRE;

ADOLESCENT; ADULT; AGED; ATTITUDE; ATTITUDE OF HEALTH PERSONNEL; DRUGS, GENERIC; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PERCEPTION; PHARMACISTS; PORTUGAL; QUESTIONNAIRES; THERAPEUTIC EQUIVALENCY;

EID: 83555165195     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2011.10.001     Document Type: Article

References (23)

1. World Health Organisation. The World health report 2010: health systems financing: the path to universal coverage. Geneva, 2010.
2. INE. Statistics of Portugal. National Health Account 2000-2008 (Portuguese). Lisbon, 2010.
3. Ministry of Health. Evolution of the National Health Plan's 2004-2010 indicators (Portuguese). Lisbon, 2010.
4. Infarmed. Market share of generic medicines in Portugal (Portuguese). Available from: (accessed 25.2.11). http://www.infarmed.pt/portal/page/portal/INFARMED/MEDICAMENTOS_USO_HUMANO/GENERICOS/QUOTAS_GENERICOS.
5. CEFAR Analysis of the generic medicine market (Portuguese). Farmácia Observatório 2010, 26:1-4.
6. European Central Bank, European Commission and International Monetary Fund. Portugal: memorandum of understanding on specific economic policy conditionality 2011. Available from: (accessed 18.5.11). http://www.bdo.pt/images/stories/docs/documentos/tax_alert/PT-Memo-Of-Understanding.pdf.
7. Kanavos P., Vandoros S., Irwin R., Nicode E., Casson M., et al. Differences in costs of and access to pharmaceutical products in the EU 2011, Medical Technology Research Group, Policy Department Economic and Scientific Policy - European Parliament, Brussels.
8. Barros P., Nunes L. 10 years of pharmaceutical policy in Portugal (Portuguese) 2011, Nova School of Business & Economics, Lisbon.
9. Barros P., Nunes L. The impact of pharmaceutical policy measures: an endogenous structural-break approach. Social Science & Medicine 2010, 71:440-450.
10. Vallès J.A., Barreiro M., Cereza G., Ferro J.J., Martínez M.J., Escribà J.M., et al. A prospective multicenter study of the effect of patient education on acceptability of generic prescribing in general practice. Health Policy 2003, 65:269-275.
11. Allenet B., Barry H. Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1000 French community pharmacists. Pharmacy World & Science 2003, 25:197-202.
12. Himmel W., Simmenroth-Nayda A., Niebling W., Ledig T., Jansen R.D., Kochen M.M., et al. What do primary care patients think about generic drugs?. International Journal of Clinical Pharmacology and Therapeutics 2005, 43:472-479.
13. Kjoenniksen I., Lindbaek M., Granas A. Patient's attitudes towards and experiences of generic drug substitution in Norway. Pharmacy World & Science 2006, 28:284-289.
14. Heikkilä R., Mäntyselkä P., Hartikainen-Herranen K., Ahonen R. Costumers' and physicians opinions of and experiences with generic substitution during the first year in Finland. Health Policy 2007, 82:366-374.
15. Anderson K., Sonesson C., Petzold M., Carlsten A., Lonnroth K. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiology and Drug Safety 2005, 14:341-348.
16. Kobayashi E., Karigome H., Sakurada T., Satoh N., Ueda S. Patients' attitudes towards generic drug substitution in Japan. Health Policy 2011, 99:60-65.
17. Chong C., March G., Clark A., Gilbert A., Hassali M.A., Bahari M.B. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy 2011, 99:139-148.
18. Figueiras M., Marcelino D., Cortes M., Horne R., Weinman J. Common sense views about generic medicines vs. branded medicines: a pilot study about gender differences (Portuguese). Análise Psicológica 2007, 3:427-437.
19. Figueiras M., Marcelino D., Cortes M. People's views on the level of agreement of generic medicines for different illnesses. Pharmacy World & Science 2008, 30:590-594.
20. Pinto G. Medicine expenses and their control, in National Health Plan 2011-2016 - The pharmaceutical policy, medical devices and health technology assessment (Portuguese). Lisbon, 2010. Available from: (acessed 18.5.11). http://www.acs.min-saude.pt/pns2011-2016/files/2010/11/PM1.pdf.
21. Teixeira S. The choice of a generic medicine: a qualitative study (Portuguese). Master Dissertation, Faculty of Economics of the University of Coimbra, December 2010.
22. INE. Statistics of Portugal. Available from: http://www.ine.pt/xportal/xmain%3Fxpgid=ine_main%26xpid=INE.
23. Johnston A., Stafylas P., Stergious G. Effectiveness, safety and cost of drug substitution in hypertension. British Journal of Clinical Pharmacology 2010, 70:320-334.